A recent study by Transparency Market Research (TMR) forecasts that the global hospital infection therapeutics market will grow at a CAGR of 3.1% between 2014 and 2020. TMR, a market intelligence company based in the United States, in its recently released report states, that the global hospital infection therapeutics market is anticipated to reach a market value worth US$3.62 billion by 2020 from US$3.06 billion in 2013. The report titled “Hospital Infection Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020” is available for sale on the website.

Browse the full Hospital Infection Therapeutics Market Report at http://www.transparencymarketresearch.com/hospital-infection-therapeutics.html


According to this market research report, a growing geriatric population, rising demand for better therapeutic drugs, high incidence of hospital infections, and greater healthcare awareness are a few of the prominent factors that drive the global hospital infection therapeutics market. The infections which the patients undergoing treatments in hospitals contract during their stay in the hospitals are known as hospital-acquired infections (HAI) or hospital infections. These infections spread in healthcare settings such as nursing homes, rehabilitation centers, hospitals, dialysis centers, and outpatient surgery centers. It has been observed that most cases of hospital infections originate from the ICUs (Intensive Care Units) as against other divisions.


The TMR report segments the global hospital infection therapeutics market on the basis of drug type, major infections, and geography. On the basis of drug type, this market is segmented into antifungal drugs, antibacterial drugs, and antiviral drugs. Based on major infections, the hospital infection therapeutics market is segmented into bloodstream infections, gastrointestinal disorders, hospital-acquired pneumonia (HAP), urinary tract infections, surgical site infections, and other hospital infections.In 2013, the largest share in the global hospital infection therapeutics market was held by the segment for hospital-acquired pneumonia, with a market share more than 20%. However, the segment for urinary tract infections will grow at a rapid rate in the forthcoming years.

Geographically, this research study classifies the global hospital infection therapeutics market into Asia Pacific, Europe, North America, and Rest of the World. In revenue terms, North America dominates the overall hospital infection therapeutics market. The second largest market after North America is Europe. High demand for advanced drugs, high incidence of hospital infections, increasing number of multidrug-resistant microbial pathogens are the key factors that propel the North America hospital infection therapeutics market. The other factors driving the North America market are high income levels and greater healthcare awareness amongst the masses. However, owing to increasing income levels, rising awareness, and better healthcare infrastructure, it is the Asia Pacific hospital infection therapeutics market that will witness highest growth rate in the years to come.


Browse the full Press Release Report :
http://www.transparencymarketresearch.com/pressrelease/hospital-infection-therapeutics.htm

Key factors that hamper the growth of the overall hospital infection therapeutics market are greater number of multi-drug resistant bacterial strains and greater infection control and hospital surveillance programs in advanced economies leading to lower incidence of hospital infections.


Some of the key companies in the global hospital infection therapeutics market include Sanofi, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, AstraZeneca plc, and Actavis plc.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1280

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com